The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours
- 4 November 2009
- journal article
- research article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 7 (4) , 230-235
- https://doi.org/10.1111/j.1476-5829.2009.00193.x
Abstract
Tumour size is considered one of the most important determinants of clinical staging in cancer patients. The aim of this study was to assess the value of tumour size as an indicator of the differentiation of mammary neoplasias in female dogs. The tumour, nodes metastates (TNM) system, based on primary lesion size, the extent of its dissemination to regional lymph nodes and the presence or absence of distant metastases, was applied to 120 female dogs diagnosed with mammary neoplasias. Paraffin blocks from 38 cases were selected and studied by immunohistochemical staining for prognostic and predictive markers of breast cancer. The Kaplan–Meier survival curve was estimated for 110 female dogs. Larger tumours (T3) were mostly malignant and showed lower expression of progesterone receptor and higher expression of cellular proliferation markers. Global survival time was shorter in female dogs with large tumour masses. This study highlights the importance of tumour size as a prognostic indicator of mammary neoplasias in female dogs.Keywords
This publication has 25 references indexed in Scilit:
- Immunohistochemical Expression of p63 and ΔNp63 in Mixed Tumors of Canine Mammary Glands and Its Relation with p53 ExpressionVeterinary Pathology, 2009
- A comparative study between mixed-type tumours from human salivary and canine mammary glandsBMC Cancer, 2007
- Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutationVeterinary and Comparative Oncology, 2007
- Cyclooxygenase -2 Expression in Mammary Tumors in Dogs and its Correlation to Histologic and Biologic BehaviorVeterinary and Comparative Oncology, 2005
- A Prospective Analysis of Immunohistochemically Determined Estrogen Receptor α and Progesterone Receptor Expression and Host and Tumor Factors as Predictors of Disease-free Period in Mammary Tumors of the DogVeterinary Pathology, 2005
- Immunohistochemical Analysis of c-yes and c-erbB-2 Oncogene Products and p53 Tumor Suppressor Protein in Canine Mammary TumorsThe Journal of Veterinary Medical Science, 1999
- Immunohistochemical Detection of Ki-67 and PCNA in Canine Mammary Tumors: Relationship to Clinical and Pathologic VariablesJournal of Veterinary Diagnostic Investigation, 1998
- Prognosis of Breast Cancer Patients after Mastectomy and Dissection of Internal Mammary NodesAnnals of Surgery, 1985
- The demonstration of oestrogen, androgen and progestagen receptors in the cytosol fraction of canine mammary tumoursPublished by Elsevier ,1979
- The prognosis following the surgical excision of canine mammary neoplasmsPublished by Elsevier ,1975